B7-H3 CAR T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for B7-H3 CAR T cell therapy, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors [Phase 1]